<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00127205</url>
  </required_header>
  <id_info>
    <org_study_id>CDR0000437061</org_study_id>
    <secondary_id>S0307</secondary_id>
    <nct_id>NCT00127205</nct_id>
  </id_info>
  <brief_title>S0307 Phase III Trial of Bisphosphonates as Adjuvant Therapy for Primary Breast Cancer.</brief_title>
  <official_title>Phase III Trial of Bisphosphonates as Adjuvant Therapy for Primary Breast Cancer</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Southwest Oncology Group</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Cancer Institute (NCI)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
    <collaborator>
      <agency>North Central Cancer Treatment Group</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Eastern Cooperative Oncology Group</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>NSABP Foundation Inc</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Cancer and Leukemia Group B</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>NCIC Clinical Trials Group</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Southwest Oncology Group</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      RATIONALE: Zoledronate, clodronate, or ibandronate may delay or prevent bone metastases in
      patients with nonmetastatic breast cancer. It is not yet known whether zoledronate is more
      effective than clodronate or ibandronate in treating breast cancer.

      PURPOSE: This randomized phase III trial is studying zoledronate to see how well it works
      compared to clodronate or ibandronate in treating women who have undergone surgery for stage
      I, stage II, or stage III breast cancer.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      OBJECTIVES:

        -  Compare disease-free survival and overall survival of women with resected primary stage
           I-III adenocarcinoma of the breast treated with adjuvant zoledronate vs clodronate vs
           ibandronate.

        -  Compare the distributions of sites of first disease recurrence in patients treated with
           these drugs.

        -  Compare adverse events in patients treated with these drugs.

        -  Correlate parathyroid hormone related protein status and N-telopeptide levels at
           baseline with disease-free survival and sites of first recurrence in patients treated
           with these drugs.

        -  Investigate whether there is an association between inherited germ-line single
           nucleotide polymorphisms (SNP, rs2297480) in farnesyl diphosphate synthase (FDPS) and
           the adverse event of acute phase reactions in these patients.

      OUTLINE: This is a randomized, multicenter study. Patients are randomized to 1 of 3 treatment
      arms.

        -  Arm I: Patients receive zoledronate IV over 15 minutes once a month for 6 months and
           then once every 3 months for 2.5 years.

        -  Arm II: Patients receive oral clodronate once daily for 35 months.

        -  Arm III: Patients receive oral ibandronate once daily for 35 months. Treatment in all
           arms continues in the absence of disease recurrence or unacceptable toxicity.

      After completion of study treatment, patients are followed every 6 months until disease
      recurrence and then annually for up to 10 years.

      PROJECTED ACCRUAL: A total of 5,400 will be accrued for this study.
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date>July 2005</start_date>
  <completion_date type="Anticipated">May 2020</completion_date>
  <primary_completion_date type="Actual">December 2017</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Disease-free Survival</measure>
    <time_frame>Disease assessments are completed every 6 months for 5 years then annually for 5 years or until death or recurrence</time_frame>
    <description>Time from date of registration to date of first observation of recurrence or death due to any cause. Patients last known to be alive who have not experienced recurrence of disease are censored at their last contact date. The outcome for the disease-free survival will be presented as 5 year survival rate.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Overall Survival</measure>
    <time_frame>follow up completed every 6 months for 5 years and then annually for 5 years or until death</time_frame>
    <description>Time from date of registration to date of death due to any cause. Patients last known to be alive are censored at their last contact date. The outcome for overall survival will be presented as 5 year overall survival rate.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Distributions of Sites of First Recurrence on the Three Arms.</measure>
    <time_frame>Disease assessments are completed every 6 months for 5 years then annually for 5 years or until death or recurrence</time_frame>
    <description>All sites of invasive disease documented within 30 days of first documentation of invasive recurrence.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Patients With Gr 3 Through 5 Adverse Events That Are Related to Study Drugs</measure>
    <time_frame>Toxicity assessment is repeated every 2 months for the first 6 months, then every 3 months until 3 years or end of treatment.</time_frame>
    <description>Adverse Events (AEs) are reported by CTCAE Version 4.0. Only adverse events that are possibly, probably or definitely related to study drug are reported.</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">6097</enrollment>
  <condition>Breast Cancer</condition>
  <arm_group>
    <arm_group_label>Arm I</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients receive zoledronate IV over 15 minutes once a month for 6 months and then once every 3 months for 2.5 years.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Arm II</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients receive oral clodronate once daily for 35 months.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Arm III</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients receive oral ibandronate once daily for 35 months.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>clodronate disodium</intervention_name>
    <description>Given orally</description>
    <arm_group_label>Arm II</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>ibandronate sodium</intervention_name>
    <description>Given orally</description>
    <arm_group_label>Arm III</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>zoledronic acid</intervention_name>
    <description>Given IV</description>
    <arm_group_label>Arm I</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        DISEASE CHARACTERISTICS:

          -  Histologically confirmed primary adenocarcinoma of the breast

               -  Stage I-III disease

               -  No evidence of metastatic disease

          -  Must have undergone lumpectomy or total mastectomy for primary disease within the past
             12 weeks, or have completed chemotherapy within the past 8 weeks

               -  Axillary evaluation per institutional standards

          -  Currently receiving or planning to receive standard adjuvant systemic therapy
             comprising chemotherapy, hormonal therapy, or combined chemotherapy/hormonal therapy
             for breast cancer

               -  Patients who are at low risk for disease recurrence and for whom adjuvant
                  systemic therapy will not be prescribed are not eligible

               -  Patients who receive biologic agents only or local radiotherapy only (without
                  chemotherapy and/or hormone therapy) are not eligible

               -  Additional therapies are allowed including radiotherapy and biologic agents
                  (e.g., trastuzumab [Herceptin^®], bevacizumab, or hematopoietic growth factors)

               -  Neoadjuvant therapy or hormonal therapy alone is allowed provided study entry
                  occurs ≥ 12 weeks after completion of surgery

          -  Patients with skeletal pain are eligible provided bone scan and/or roentgenological
             exam are negative for metastatic disease

               -  Suspicious findings must be confirmed as benign by x-ray, MRI, or biopsy

          -  Hormone receptor status:

               -  Not specified

        PATIENT CHARACTERISTICS:

        Age

          -  18 and over

        Sex

          -  Female

        Menopausal status

          -  Not specified

        Performance status

          -  Zubrod 0-2

        Life expectancy

          -  Not specified

        Hematopoietic

          -  Not specified

        Hepatic

          -  Not specified

        Renal

          -  Creatinine ≤ 2 times upper limit of normal

          -  Creatinine clearance ≥ 30 mL/min

          -  No renal failure

        Other

          -  Not pregnant or nursing

          -  Negative pregnancy test

          -  Fertile patients must use effective contraception

          -  No history of esophageal stricture or motility disorders

               -  Gastroesophageal reflux disorder allowed

          -  No other malignancy within the past 5 years except adequately treated basal cell or
             squamous cell skin cancer, carcinoma in situ of the cervix, or adequately treated
             stage I or II cancer in complete remission

        PRIOR CONCURRENT THERAPY:

        Biologic therapy

          -  Prior or concurrent hematopoietic growth factors allowed

          -  HER-2-targeted therapies allowed

          -  Antiangiogenics allowed

        Chemotherapy

          -  See Disease Characteristics

        Endocrine therapy

          -  See Disease Characteristics

        Radiotherapy

          -  Concurrent radiotherapy to the breast, chest wall, or lymph node group allowed at the
             discretion of the treating physician

        Surgery

          -  See Disease Characteristics

        Other

          -  Prior neoadjuvant therapy allowed

          -  Prior bisphosphonates for bone density allowed

          -  No other concurrent bisphosphonates as adjuvant therapy or for treatment of
             osteoporosis

          -  No concurrent enrollment in clinical trials with bone density as an endpoint

               -  Concurrent enrollment on any other locoregional or systemic therapy breast cancer
                  study (including cooperative group studies) allowed
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Julie R. Gralow, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Seattle Cancer Care Alliance</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Robert B. Livingston, MD</last_name>
    <role>Study Chair</role>
    <affiliation>University of Arizona</affiliation>
  </overall_official>
  <overall_official>
    <last_name>James N. Ingle, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Mayo Clinic</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Carla I. Falkson, MD</last_name>
    <role>Study Chair</role>
    <affiliation>University of Alabama at Birmingham</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Alexander H Paterson, MD, FRCP</last_name>
    <role>Study Chair</role>
    <affiliation>Tom Baker Cancer Centre - Calgary</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Elizabeth C. Dees, MD</last_name>
    <role>Study Chair</role>
    <affiliation>UNC Lineberger Comprehensive Cancer Center</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Mark J. Clemons, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Toronto Sunnybrook Regional Cancer Centre</affiliation>
  </overall_official>
  <removed_countries>
    <country>Canada</country>
    <country>United States</country>
  </removed_countries>
  <verification_date>August 2019</verification_date>
  <study_first_submitted>August 3, 2005</study_first_submitted>
  <study_first_submitted_qc>August 3, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 5, 2005</study_first_posted>
  <results_first_submitted>June 20, 2019</results_first_submitted>
  <results_first_submitted_qc>August 15, 2019</results_first_submitted_qc>
  <results_first_posted type="Actual">August 28, 2019</results_first_posted>
  <last_update_submitted>August 29, 2019</last_update_submitted>
  <last_update_submitted_qc>August 29, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">September 3, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>stage I breast cancer</keyword>
  <keyword>stage II breast cancer</keyword>
  <keyword>stage IIIA breast cancer</keyword>
  <keyword>stage IIIB breast cancer</keyword>
  <keyword>stage IIIC breast cancer</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Breast Neoplasms</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Zoledronic Acid</mesh_term>
    <mesh_term>Ibandronic Acid</mesh_term>
    <mesh_term>Clodronic Acid</mesh_term>
  </intervention_browse>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol, Statistical Analysis Plan, and Informed Consent Form</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>Yes</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>December 19, 2014</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/05/NCT00127205/Prot_SAP_ICF_000.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Arm I Zoledronate</title>
          <description>Patients receive zoledronate IV over 15 minutes once a month for 6 months and then once every 3 months for 2.5 years.
zoledronic acid: Given IV</description>
        </group>
        <group group_id="P2">
          <title>Arm II Clodronate</title>
          <description>Patients receive oral clodronate once daily for 35 months.
clodronate disodium: Given orally</description>
        </group>
        <group group_id="P3">
          <title>Arm III Ibandronate</title>
          <description>Patients receive oral ibandronate once daily for 35 months.
ibandronate sodium: Given orally</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="2262"/>
                <participants group_id="P2" count="2268"/>
                <participants group_id="P3" count="1567"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="1427"/>
                <participants group_id="P2" count="1288"/>
                <participants group_id="P3" count="950"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="835"/>
                <participants group_id="P2" count="980"/>
                <participants group_id="P3" count="617"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Adverse Event</title>
              <participants_list>
                <participants group_id="P1" count="228"/>
                <participants group_id="P2" count="386"/>
                <participants group_id="P3" count="272"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Death</title>
              <participants_list>
                <participants group_id="P1" count="8"/>
                <participants group_id="P2" count="6"/>
                <participants group_id="P3" count="6"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="318"/>
                <participants group_id="P2" count="308"/>
                <participants group_id="P3" count="172"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Other-non protocol specified</title>
              <participants_list>
                <participants group_id="P1" count="141"/>
                <participants group_id="P2" count="129"/>
                <participants group_id="P3" count="77"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Under Review</title>
              <participants_list>
                <participants group_id="P1" count="13"/>
                <participants group_id="P2" count="21"/>
                <participants group_id="P3" count="6"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Progression</title>
              <participants_list>
                <participants group_id="P1" count="127"/>
                <participants group_id="P2" count="130"/>
                <participants group_id="P3" count="84"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>Only eligible patients are included in the analysis.</population>
      <group_list>
        <group group_id="B1">
          <title>Arm I Zoledronate</title>
          <description>Patients receive zoledronate IV over 15 minutes once a month for 6 months and then once every 3 months for 2.5 years.
zoledronic acid: Given IV</description>
        </group>
        <group group_id="B2">
          <title>Arm II Clodronate</title>
          <description>Patients receive oral clodronate once daily for 35 months.
clodronate disodium: Given orally</description>
        </group>
        <group group_id="B3">
          <title>Arm III Ibandronate</title>
          <description>Patients receive oral ibandronate once daily for 35 months.
ibandronate sodium: Given orally</description>
        </group>
        <group group_id="B4">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="2231"/>
            <count group_id="B2" value="2235"/>
            <count group_id="B3" value="1552"/>
            <count group_id="B4" value="6018"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Median</param>
          <dispersion>Full Range</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="53.0" lower_limit="24.8" upper_limit="85.7"/>
                    <measurement group_id="B2" value="52.6" lower_limit="21.2" upper_limit="86.1"/>
                    <measurement group_id="B3" value="52.7" lower_limit="26.1" upper_limit="85.8"/>
                    <measurement group_id="B4" value="52.7" lower_limit="21.2" upper_limit="86.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age, Customized</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>Age, Categorized</title>
              <category_list>
                <category>
                  <title>Age &lt; 55</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1270"/>
                    <measurement group_id="B2" value="1304"/>
                    <measurement group_id="B3" value="894"/>
                    <measurement group_id="B4" value="3468"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Age &gt;= 55</title>
                  <measurement_list>
                    <measurement group_id="B1" value="961"/>
                    <measurement group_id="B2" value="931"/>
                    <measurement group_id="B3" value="658"/>
                    <measurement group_id="B4" value="2550"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="2231"/>
                    <measurement group_id="B2" value="2235"/>
                    <measurement group_id="B3" value="1552"/>
                    <measurement group_id="B4" value="6018"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>American Indian or Alaska Native</title>
                  <measurement_list>
                    <measurement group_id="B1" value="12"/>
                    <measurement group_id="B2" value="8"/>
                    <measurement group_id="B3" value="4"/>
                    <measurement group_id="B4" value="24"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Asian</title>
                  <measurement_list>
                    <measurement group_id="B1" value="70"/>
                    <measurement group_id="B2" value="90"/>
                    <measurement group_id="B3" value="57"/>
                    <measurement group_id="B4" value="217"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Native Hawaiian or Other Pacific Islander</title>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                    <measurement group_id="B2" value="2"/>
                    <measurement group_id="B3" value="3"/>
                    <measurement group_id="B4" value="7"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Black or African American</title>
                  <measurement_list>
                    <measurement group_id="B1" value="129"/>
                    <measurement group_id="B2" value="118"/>
                    <measurement group_id="B3" value="85"/>
                    <measurement group_id="B4" value="332"/>
                  </measurement_list>
                </category>
                <category>
                  <title>White</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1975"/>
                    <measurement group_id="B2" value="1976"/>
                    <measurement group_id="B3" value="1374"/>
                    <measurement group_id="B4" value="5325"/>
                  </measurement_list>
                </category>
                <category>
                  <title>More than one race</title>
                  <measurement_list>
                    <measurement group_id="B1" value="12"/>
                    <measurement group_id="B2" value="5"/>
                    <measurement group_id="B3" value="2"/>
                    <measurement group_id="B4" value="19"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="31"/>
                    <measurement group_id="B2" value="36"/>
                    <measurement group_id="B3" value="27"/>
                    <measurement group_id="B4" value="94"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Nodal Status</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>Negative</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1089"/>
                    <measurement group_id="B2" value="1152"/>
                    <measurement group_id="B3" value="784"/>
                    <measurement group_id="B4" value="3025"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1~3</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="722"/>
                    <measurement group_id="B2" value="685"/>
                    <measurement group_id="B3" value="489"/>
                    <measurement group_id="B4" value="1896"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>&gt;=4</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="404"/>
                    <measurement group_id="B2" value="385"/>
                    <measurement group_id="B3" value="267"/>
                    <measurement group_id="B4" value="1056"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>ER/PR</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>Negative (ER-, PR-)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="480"/>
                    <measurement group_id="B2" value="487"/>
                    <measurement group_id="B3" value="319"/>
                    <measurement group_id="B4" value="1286"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Positive (ER+ or PR+)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1747"/>
                    <measurement group_id="B2" value="1747"/>
                    <measurement group_id="B3" value="1231"/>
                    <measurement group_id="B4" value="4725"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>HER2 status</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>HER2 negative</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1787"/>
                    <measurement group_id="B2" value="1786"/>
                    <measurement group_id="B3" value="1247"/>
                    <measurement group_id="B4" value="4820"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>HER2 positive/equivocal</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="418"/>
                    <measurement group_id="B2" value="427"/>
                    <measurement group_id="B3" value="288"/>
                    <measurement group_id="B4" value="1133"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Breast disease subtype</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>ER+ or PR+, HER2-</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1437"/>
                    <measurement group_id="B2" value="1419"/>
                    <measurement group_id="B3" value="1015"/>
                    <measurement group_id="B4" value="3871"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>ER+ or PR+, HER2+</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="292"/>
                    <measurement group_id="B2" value="312"/>
                    <measurement group_id="B3" value="205"/>
                    <measurement group_id="B4" value="809"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>ER/PR-, HER2- (triple neg)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="350"/>
                    <measurement group_id="B2" value="367"/>
                    <measurement group_id="B3" value="232"/>
                    <measurement group_id="B4" value="949"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>ER/PR-, HER2+ (triple neg)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="126"/>
                    <measurement group_id="B2" value="115"/>
                    <measurement group_id="B3" value="83"/>
                    <measurement group_id="B4" value="324"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Stage</title>
          <description>Staging criterial is per AJCC 6th Edition, 2002.</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>Stage I</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="721"/>
                    <measurement group_id="B2" value="770"/>
                    <measurement group_id="B3" value="509"/>
                    <measurement group_id="B4" value="2000"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Stage II</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="992"/>
                    <measurement group_id="B2" value="954"/>
                    <measurement group_id="B3" value="694"/>
                    <measurement group_id="B4" value="2640"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Stage III</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="472"/>
                    <measurement group_id="B2" value="460"/>
                    <measurement group_id="B3" value="304"/>
                    <measurement group_id="B4" value="1236"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Chemotherapy</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>Not given or planned</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="446"/>
                    <measurement group_id="B2" value="454"/>
                    <measurement group_id="B3" value="319"/>
                    <measurement group_id="B4" value="1219"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Given or planned</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1779"/>
                    <measurement group_id="B2" value="1778"/>
                    <measurement group_id="B3" value="1232"/>
                    <measurement group_id="B4" value="4789"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Hormonal Therapy</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>Not given or planned</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="542"/>
                    <measurement group_id="B2" value="535"/>
                    <measurement group_id="B3" value="367"/>
                    <measurement group_id="B4" value="1444"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Given or planned</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1670"/>
                    <measurement group_id="B2" value="1686"/>
                    <measurement group_id="B3" value="1170"/>
                    <measurement group_id="B4" value="4526"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Disease-free Survival</title>
        <description>Time from date of registration to date of first observation of recurrence or death due to any cause. Patients last known to be alive who have not experienced recurrence of disease are censored at their last contact date. The outcome for the disease-free survival will be presented as 5 year survival rate.</description>
        <time_frame>Disease assessments are completed every 6 months for 5 years then annually for 5 years or until death or recurrence</time_frame>
        <population>Only eligible patients will be included in the analysis.</population>
        <group_list>
          <group group_id="O1">
            <title>Arm I Zoledronate</title>
            <description>Patients receive zoledronate IV over 15 minutes once a month for 6 months and then once every 3 months for 2.5 years.
zoledronic acid: Given IV</description>
          </group>
          <group group_id="O2">
            <title>Arm II Clodronate</title>
            <description>Patients receive oral clodronate once daily for 35 months.
clodronate disodium: Given orally</description>
          </group>
          <group group_id="O3">
            <title>Arm III Ibandronate</title>
            <description>Patients receive oral ibandronate once daily for 35 months.
ibandronate sodium: Given orally</description>
          </group>
        </group_list>
        <measure>
          <title>Disease-free Survival</title>
          <description>Time from date of registration to date of first observation of recurrence or death due to any cause. Patients last known to be alive who have not experienced recurrence of disease are censored at their last contact date. The outcome for the disease-free survival will be presented as 5 year survival rate.</description>
          <population>Only eligible patients will be included in the analysis.</population>
          <units>percentage of analyzed participants</units>
          <param>Number</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="2231"/>
                <count group_id="O2" value="2235"/>
                <count group_id="O3" value="1552"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="88" lower_limit="87" upper_limit="90"/>
                    <measurement group_id="O2" value="88" lower_limit="86" upper_limit="89"/>
                    <measurement group_id="O3" value="87" lower_limit="86" upper_limit="89"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Other</non_inferiority_type>
            <p_value>0.49</p_value>
            <method>Log Rank</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.24</p_value>
            <method>Regression, Cox</method>
            <param_type>Hazard Ratio (HR)</param_type>
            <param_value>1.09</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.94</ci_lower_limit>
            <ci_upper_limit>1.26</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.50</p_value>
            <method>Regression, Cox</method>
            <param_type>Hazard Ratio (HR)</param_type>
            <param_value>1.06</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.90</ci_lower_limit>
            <ci_upper_limit>1.24</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Overall Survival</title>
        <description>Time from date of registration to date of death due to any cause. Patients last known to be alive are censored at their last contact date. The outcome for overall survival will be presented as 5 year overall survival rate.</description>
        <time_frame>follow up completed every 6 months for 5 years and then annually for 5 years or until death</time_frame>
        <population>Only eligible patients will be included in the analysis.</population>
        <group_list>
          <group group_id="O1">
            <title>Arm I Zoledronate</title>
            <description>Patients receive zoledronate IV over 15 minutes once a month for 6 months and then once every 3 months for 2.5 years.
zoledronic acid: Given IV</description>
          </group>
          <group group_id="O2">
            <title>Arm II Clodronate</title>
            <description>Patients receive oral clodronate once daily for 35 months.
clodronate disodium: Given orally</description>
          </group>
          <group group_id="O3">
            <title>Arm III Ibandronate</title>
            <description>Patients receive oral ibandronate once daily for 35 months.
ibandronate sodium: Given orally</description>
          </group>
        </group_list>
        <measure>
          <title>Overall Survival</title>
          <description>Time from date of registration to date of death due to any cause. Patients last known to be alive are censored at their last contact date. The outcome for overall survival will be presented as 5 year overall survival rate.</description>
          <population>Only eligible patients will be included in the analysis.</population>
          <units>percentage of analyzable patients</units>
          <param>Number</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="2231"/>
                <count group_id="O2" value="2235"/>
                <count group_id="O3" value="1552"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="93" lower_limit="91" upper_limit="94"/>
                    <measurement group_id="O2" value="92" lower_limit="91" upper_limit="94"/>
                    <measurement group_id="O3" value="93" lower_limit="92" upper_limit="94"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Other</non_inferiority_type>
            <p_value>0.50</p_value>
            <method>Log Rank</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Distributions of Sites of First Recurrence on the Three Arms.</title>
        <description>All sites of invasive disease documented within 30 days of first documentation of invasive recurrence.</description>
        <time_frame>Disease assessments are completed every 6 months for 5 years then annually for 5 years or until death or recurrence</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Arm I Zoledronate</title>
            <description>Patients receive zoledronate IV over 15 minutes once a month for 6 months and then once every 3 months for 2.5 years.
zoledronic acid: Given IV</description>
          </group>
          <group group_id="O2">
            <title>Arm II Clodronate</title>
            <description>Patients receive oral clodronate once daily for 35 months.
clodronate disodium: Given orally</description>
          </group>
          <group group_id="O3">
            <title>Arm III Ibandronate</title>
            <description>Patients receive oral ibandronate once daily for 35 months.
ibandronate sodium: Given orally</description>
          </group>
        </group_list>
        <measure>
          <title>Distributions of Sites of First Recurrence on the Three Arms.</title>
          <description>All sites of invasive disease documented within 30 days of first documentation of invasive recurrence.</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="2231"/>
                <count group_id="O2" value="2235"/>
                <count group_id="O3" value="1552"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Local/Regional only</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="41"/>
                    <measurement group_id="O2" value="55"/>
                    <measurement group_id="O3" value="36"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Contralateral only</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="17"/>
                    <measurement group_id="O2" value="18"/>
                    <measurement group_id="O3" value="17"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Distant recurrence</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="218"/>
                    <measurement group_id="O2" value="207"/>
                    <measurement group_id="O3" value="146"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Unknown location of recurrence</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="10"/>
                    <measurement group_id="O2" value="15"/>
                    <measurement group_id="O3" value="10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Bone as 1st site of distant recurrence</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="110"/>
                    <measurement group_id="O2" value="108"/>
                    <measurement group_id="O3" value="82"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Bone only</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="62"/>
                    <measurement group_id="O2" value="48"/>
                    <measurement group_id="O3" value="44"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Bone and nodes only</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                    <measurement group_id="O2" value="2"/>
                    <measurement group_id="O3" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Bone and other distant sites (beside nodes)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="46"/>
                    <measurement group_id="O2" value="58"/>
                    <measurement group_id="O3" value="36"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Liver/lung/other visceral without bone recurrence</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="57"/>
                    <measurement group_id="O2" value="67"/>
                    <measurement group_id="O3" value="40"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Brain/other CNS (+/- any other site)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="31"/>
                    <measurement group_id="O2" value="24"/>
                    <measurement group_id="O3" value="22"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>Statistical analysis for recurrence to bone</groups_desc>
            <non_inferiority_type>Other</non_inferiority_type>
            <p_value>0.93</p_value>
            <method>Log Rank</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Patients With Gr 3 Through 5 Adverse Events That Are Related to Study Drugs</title>
        <description>Adverse Events (AEs) are reported by CTCAE Version 4.0. Only adverse events that are possibly, probably or definitely related to study drug are reported.</description>
        <time_frame>Toxicity assessment is repeated every 2 months for the first 6 months, then every 3 months until 3 years or end of treatment.</time_frame>
        <population>Patients who received at least one dose of protocol treatment.</population>
        <group_list>
          <group group_id="O1">
            <title>Arm I Zoledronic Acid</title>
            <description>Patients receive zoledronate IV over 15 minutes once a month for 6 months and then once every 3 months for 2.5 years.
zoledronic acid: Given IV</description>
          </group>
          <group group_id="O2">
            <title>Arm II Clodronate</title>
            <description>Patients receive oral clodronate once daily for 35 months.
clodronate disodium: Given orally</description>
          </group>
          <group group_id="O3">
            <title>Arm III Ibandronate</title>
            <description>Arm III Ibandronate
Patients receive oral ibandronate once daily for 35 months.
ibandronate sodium: Given orally</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Patients With Gr 3 Through 5 Adverse Events That Are Related to Study Drugs</title>
          <description>Adverse Events (AEs) are reported by CTCAE Version 4.0. Only adverse events that are possibly, probably or definitely related to study drug are reported.</description>
          <population>Patients who received at least one dose of protocol treatment.</population>
          <units>Participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="2113"/>
                <count group_id="O2" value="2169"/>
                <count group_id="O3" value="1518"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>ALT, SGPT (serum glutamic pyruvic transaminase)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="3"/>
                    <measurement group_id="O3" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>AST, SGOT</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="5"/>
                    <measurement group_id="O3" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Alkaline phosphatase</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Allergic reaction/hypersensitivity</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Anorexia</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Arthritis (non-septic)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5"/>
                    <measurement group_id="O2" value="2"/>
                    <measurement group_id="O3" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Auditory/Ear-Other (Specify)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Bilirubin (hyperbilirubinemia)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Blood/Bone Marrow-Other (Specify)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CNS cerebrovascular ischemia</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Calcium, serum-low (hypocalcemia)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3"/>
                    <measurement group_id="O2" value="2"/>
                    <measurement group_id="O3" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Cardiac General-Other (Specify)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Confusion</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Constipation</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Creatinine</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Dehydration</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="2"/>
                    <measurement group_id="O3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Dental: periodontal disease</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Dental: teeth</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Diarrhea</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                    <measurement group_id="O2" value="11"/>
                    <measurement group_id="O3" value="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Distention/bloating, abdominal</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Dizziness</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="3"/>
                    <measurement group_id="O3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Dysphagia (difficulty swallowing)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Dyspnea (shortness of breath)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3"/>
                    <measurement group_id="O2" value="2"/>
                    <measurement group_id="O3" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Edema: limb</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Endocrine-Other (Specify)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Esophagitis</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="2"/>
                    <measurement group_id="O3" value="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Extremity-upper (function)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Fatigue (asthenia, lethargy, malaise)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="11"/>
                    <measurement group_id="O2" value="10"/>
                    <measurement group_id="O3" value="7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Febrile neutropenia</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Fever in absence of neutropenia, ANC lt1.0x10e9/L</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Flu-like syndrome</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Fracture</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="3"/>
                    <measurement group_id="O3" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Gastritis (including bile reflux gastritis)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Glucose, serum-high (hyperglycemia)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="2"/>
                    <measurement group_id="O3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Heartburn/dyspepsia</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                    <measurement group_id="O2" value="22"/>
                    <measurement group_id="O3" value="22"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Hemoglobin</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3"/>
                    <measurement group_id="O2" value="2"/>
                    <measurement group_id="O3" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Hemorrhage, GI - Rectum</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Hemorrhage, GI - Stomach</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Hot flashes/flushes</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3"/>
                    <measurement group_id="O2" value="5"/>
                    <measurement group_id="O3" value="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Hypertension</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                    <measurement group_id="O2" value="2"/>
                    <measurement group_id="O3" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Hypotension</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>INR (of prothrombin time)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Incontinence, urinary</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Inf (clin/microbio) w/Gr 3-4 neuts - Skin</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Inf (clin/microbio) w/Gr 3-4 neuts - Soft tissue</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Inf w/normal ANC or Gr 1-2 neutrophils - Bone</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Inf w/normal ANC or Gr 1-2 neutrophils - Bronchus</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Inf w/normal ANC or Gr 1-2 neutrophils - Dental</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Infection with unknown ANC - Appendix</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Infection with unknown ANC - Liver</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Infection with unknown ANC - Skin (cellulitis)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Insomnia</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="3"/>
                    <measurement group_id="O3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Irregular menses (change from baseline)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Irritability (children lt3 years of age)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Joint-function</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Left ventricular systolic dysfunction</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Leukocytes (total WBC)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Lymphopenia</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                    <measurement group_id="O2" value="3"/>
                    <measurement group_id="O3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Magnesium, serum-high (hypermagnesemia)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="2"/>
                    <measurement group_id="O3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Magnesium, serum-low (hypomagnesemia)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Masculinization of female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Memory impairment</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Metabolic/Laboratory-Other (Specify)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Mood alteration - anxiety</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Mood alteration - depression</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Mood alteration - euphoria</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Mucositis/stomatitis (clinical exam) - Oral cavity</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Muscle weakness, not d/t neuropathy - Extrem-lower</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Muscle weakness, not d/t neuropathy - Extrem-upper</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Muscle weakness, not d/t neuropathy - body/general</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Nausea</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3"/>
                    <measurement group_id="O2" value="5"/>
                    <measurement group_id="O3" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Neuropathy: motor</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Neuropathy: sensory</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="6"/>
                    <measurement group_id="O3" value="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Neutrophils/granulocytes (ANC/AGC)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6"/>
                    <measurement group_id="O2" value="5"/>
                    <measurement group_id="O3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Obesity</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Opportunistic inf associated w/gt=Gr 2 lymphopenia</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Osteonecrosis (avascular necrosis)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Pain - Abdomen NOS</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Pain - Back</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3"/>
                    <measurement group_id="O2" value="2"/>
                    <measurement group_id="O3" value="6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Pain - Bone</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="47"/>
                    <measurement group_id="O2" value="19"/>
                    <measurement group_id="O3" value="19"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Pain - Chest wall</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Pain - Chest/thorax NOS</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Pain - Extremity-limb</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4"/>
                    <measurement group_id="O2" value="3"/>
                    <measurement group_id="O3" value="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Pain - Head/headache</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8"/>
                    <measurement group_id="O2" value="3"/>
                    <measurement group_id="O3" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Pain - Joint</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="39"/>
                    <measurement group_id="O2" value="35"/>
                    <measurement group_id="O3" value="42"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Pain - Muscle</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="23"/>
                    <measurement group_id="O2" value="5"/>
                    <measurement group_id="O3" value="16"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Pain - Neck</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Pain - Neuralgia/peripheral nerve</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Pain - Oral cavity</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Pain - Pain NOS</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Pain - Stomach</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Pain - Throat/pharynx/larynx</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Pain - Vagina</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Pain-Other (Specify)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4"/>
                    <measurement group_id="O2" value="4"/>
                    <measurement group_id="O3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Pancreatitis</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Perforation, GI - Duodenum</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Phosphate, serum-low (hypophosphatemia)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="19"/>
                    <measurement group_id="O2" value="6"/>
                    <measurement group_id="O3" value="8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Platelets</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Potassium, serum-high (hyperkalemia)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Potassium, serum-low (hypokalemia)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="5"/>
                    <measurement group_id="O3" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Proteinuria</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Pruritus/itching</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Rash/desquamation</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="3"/>
                    <measurement group_id="O3" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Renal failure</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                    <measurement group_id="O2" value="2"/>
                    <measurement group_id="O3" value="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Renal/Genitourinary-Other (Specify)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Retinal detachment</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Rigors/chills</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Secondary Malignancy-poss rel to cancer Tx</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Sexual/Reproductive Function-Other (Specify)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Sodium, serum-low (hyponatremia)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Soft tissue necrosis - Head</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Syncope (fainting)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Thrombosis/embolism (vascular access-related)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Thrombosis/thrombus/embolism</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Tinnitus</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Urticaria (hives, welts, wheals)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="2"/>
                    <measurement group_id="O3" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Vomiting</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Weight gain</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Weight loss</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Toxicity assessment is repeated every 2 months for the first 6 months, then every 3 months until 3 years or end of treatment.</time_frame>
      <desc>For Adverse Event assessment, we include patients who are eligible and evaluable for adverse events (e.g., received at least one dose of protocol treatment) in the analysis. For all-cause mortality, we include all eligible patients in the analysis.</desc>
      <group_list>
        <group group_id="E1">
          <title>Arm I Zoledronic Acid</title>
          <description>Patients receive zoledronate IV over 15 minutes once a month for 6 months and then once every 3 months for 2.5 years.
zoledronic acid: Given IV</description>
        </group>
        <group group_id="E2">
          <title>Arm II Clodronate</title>
          <description>Patients receive oral clodronate once daily for 35 months.
clodronate disodium: Given orally</description>
        </group>
        <group group_id="E3">
          <title>Arm III Ibandronate</title>
          <description>Patients receive oral ibandronate once daily for 35 months.
ibandronate sodium: Given orally</description>
        </group>
      </group_list>
      <serious_events>
        <default_vocab>CTCAE (3.0)</default_vocab>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="238" subjects_at_risk="2231"/>
                <counts group_id="E2" subjects_affected="263" subjects_at_risk="2235"/>
                <counts group_id="E3" subjects_affected="182" subjects_at_risk="1552"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="21" subjects_at_risk="2125"/>
                <counts group_id="E2" subjects_affected="190" subjects_at_risk="2186"/>
                <counts group_id="E3" subjects_affected="141" subjects_at_risk="1530"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Blood and lymphatic system disorders</title>
            <event_list>
              <event>
                <sub_title>Febrile neutropenia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2125"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="2186"/>
                <counts group_id="E3" subjects_affected="6" subjects_at_risk="1530"/>
              </event>
              <event>
                <sub_title>Hemoglobin</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2125"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="2186"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="1530"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>Cardiac General-Other</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2125"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2186"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="1530"/>
              </event>
              <event>
                <sub_title>Cardiac-ischemia/infarction</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2125"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2186"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="1530"/>
              </event>
              <event>
                <sub_title>Conduction abnorm/AV block - Sick sinus syndrome</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2125"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2186"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="1530"/>
              </event>
              <event>
                <sub_title>Left ventricular diastolic dysfunction</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2125"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="2186"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="1530"/>
              </event>
              <event>
                <sub_title>Left ventricular systolic dysfunction</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2125"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2186"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="1530"/>
              </event>
              <event>
                <sub_title>Pain - Cardiac/heart</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2125"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="2186"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="1530"/>
              </event>
              <event>
                <sub_title>Palpitations</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2125"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2186"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="1530"/>
              </event>
              <event>
                <sub_title>Pericardial effusion (non-malignant)</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2125"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2186"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="1530"/>
              </event>
              <event>
                <sub_title>SVT and nodal arrhythmia - Atrial fibrillation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2125"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="2186"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="1530"/>
              </event>
              <event>
                <sub_title>SVT and nodal arrhythmia - Atrial tachycardia/PAT</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2125"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2186"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="1530"/>
              </event>
              <event>
                <sub_title>SVT and nodal arrhythmia - SVT tachycardia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2125"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2186"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="1530"/>
              </event>
              <event>
                <sub_title>SVT and nodal arrhythmia - Sinus bradycardia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2125"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2186"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="1530"/>
              </event>
              <event>
                <sub_title>SVT and nodal arrhythmia - Sinus tachycardia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2125"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2186"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="1530"/>
              </event>
              <event>
                <sub_title>Valvular heart disease</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2125"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2186"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="1530"/>
              </event>
              <event>
                <sub_title>Ventricular arrhythmia - PVCs</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2125"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2186"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="1530"/>
              </event>
              <event>
                <sub_title>Ventricular arrhythmia - Ventricular fibrillation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2125"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2186"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="1530"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Endocrine disorders</title>
            <event_list>
              <event>
                <sub_title>Endocrine-Other</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2125"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2186"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="1530"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Eye disorders</title>
            <event_list>
              <event>
                <sub_title>Ocular/Visual-Other</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2125"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2186"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="1530"/>
              </event>
              <event>
                <sub_title>Vision-blurred vision</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2125"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2186"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="1530"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Colitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2125"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2186"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="1530"/>
              </event>
              <event>
                <sub_title>Constipation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2125"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2186"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="1530"/>
              </event>
              <event>
                <sub_title>Dental: periodontal disease</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2125"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2186"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="1530"/>
              </event>
              <event>
                <sub_title>Diarrhea</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2125"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="2186"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="1530"/>
              </event>
              <event>
                <sub_title>Distention/bloating, abdominal</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2125"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2186"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="1530"/>
              </event>
              <event>
                <sub_title>Esophagitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2125"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2186"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="1530"/>
              </event>
              <event>
                <sub_title>Fistula, GI - Colon/cecum/appendix</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2125"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2186"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="1530"/>
              </event>
              <event>
                <sub_title>Gastritis (including bile reflux gastritis)</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2125"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2186"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="1530"/>
              </event>
              <event>
                <sub_title>Gastrointestinal-Other</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2125"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2186"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="1530"/>
              </event>
              <event>
                <sub_title>Hemorrhage, GI - Cecum/appendix</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2125"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2186"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="1530"/>
              </event>
              <event>
                <sub_title>Hemorrhage, GI - Esophagus</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2125"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2186"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="1530"/>
              </event>
              <event>
                <sub_title>Hemorrhage, GI - Stomach</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2125"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2186"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="1530"/>
              </event>
              <event>
                <sub_title>Hemorrhage, GI - Varices (rectal)</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2125"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2186"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="1530"/>
              </event>
              <event>
                <sub_title>Nausea</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2125"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2186"/>
                <counts group_id="E3" subjects_affected="5" subjects_at_risk="1530"/>
              </event>
              <event>
                <sub_title>Obstruction, GI - Cecum</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2125"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2186"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="1530"/>
              </event>
              <event>
                <sub_title>Obstruction, GI - Small bowel NOS</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2125"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="2186"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="1530"/>
              </event>
              <event>
                <sub_title>Obstruction, GI - Stomach</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2125"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2186"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="1530"/>
              </event>
              <event>
                <sub_title>Pain - Abdomen NOS</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2125"/>
                <counts group_id="E2" subjects_affected="10" subjects_at_risk="2186"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="1530"/>
              </event>
              <event>
                <sub_title>Pancreatitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2125"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="2186"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="1530"/>
              </event>
              <event>
                <sub_title>Perforation, GI - Duodenum</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2125"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2186"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="1530"/>
              </event>
              <event>
                <sub_title>Ulcer, GI - Stomach</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2125"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2186"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="1530"/>
              </event>
              <event>
                <sub_title>Vomiting</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2125"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2186"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="1530"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Death not associated with CTCAE term - Death NOS</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2125"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2186"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="1530"/>
              </event>
              <event>
                <sub_title>Edema: head and neck</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2125"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2186"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="1530"/>
              </event>
              <event>
                <sub_title>Edema: limb</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2125"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2186"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="1530"/>
              </event>
              <event>
                <sub_title>Fatigue (asthenia, lethargy, malaise)</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2125"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="2186"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="1530"/>
              </event>
              <event>
                <sub_title>Pain - Chest/thorax NOS</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2125"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2186"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="1530"/>
              </event>
              <event>
                <sub_title>Pain - Pain NOS</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2125"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2186"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="1530"/>
              </event>
              <event>
                <sub_title>Pain-Other</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2125"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2186"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="1530"/>
              </event>
              <event>
                <sub_title>Sudden death</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2125"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2186"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="1530"/>
              </event>
              <event>
                <sub_title>Syndromes-Other</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2125"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2186"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="1530"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Hepatobiliary disorders</title>
            <event_list>
              <event>
                <sub_title>Cholecystitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2125"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="2186"/>
                <counts group_id="E3" subjects_affected="7" subjects_at_risk="1530"/>
              </event>
              <event>
                <sub_title>Liver dysfunction/failure (clinical)</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2125"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2186"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="1530"/>
              </event>
              <event>
                <sub_title>Pain - Liver</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2125"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2186"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="1530"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Immune system disorders</title>
            <event_list>
              <event>
                <sub_title>Allergic reaction/hypersensitivity</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2125"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="2186"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="1530"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Inf (clin/microbio) w/Gr 3-4 neuts - Blood</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2125"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="2186"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="1530"/>
              </event>
              <event>
                <sub_title>Inf (clin/microbio) w/Gr 3-4 neuts - Catheter-rel</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2125"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2186"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="1530"/>
              </event>
              <event>
                <sub_title>Inf (clin/microbio) w/Gr 3-4 neuts - Sinus</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2125"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2186"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="1530"/>
              </event>
              <event>
                <sub_title>Inf (clin/microbio) w/Gr 3-4 neuts - Skin</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2125"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2186"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="1530"/>
              </event>
              <event>
                <sub_title>Inf w/normal ANC or Gr 1-2 neutrophils - Blood</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2125"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2186"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="1530"/>
              </event>
              <event>
                <sub_title>Inf w/normal ANC or Gr 1-2 neutrophils - Bronchus</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2125"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2186"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="1530"/>
              </event>
              <event>
                <sub_title>Inf w/normal ANC or Gr 1-2 neutrophils - Catheter</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2125"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2186"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="1530"/>
              </event>
              <event>
                <sub_title>Inf w/normal ANC or Gr 1-2 neutrophils - Colon</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2125"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2186"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="1530"/>
              </event>
              <event>
                <sub_title>Inf w/normal ANC or Gr 1-2 neutrophils - Kidney</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2125"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2186"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="1530"/>
              </event>
              <event>
                <sub_title>Inf w/normal ANC or Gr 1-2 neutrophils - Lung</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2125"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="2186"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="1530"/>
              </event>
              <event>
                <sub_title>Inf w/normal ANC or Gr 1-2 neutrophils - Lymphatic</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2125"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2186"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="1530"/>
              </event>
              <event>
                <sub_title>Inf w/normal ANC or Gr 1-2 neutrophils - Skin</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2125"/>
                <counts group_id="E2" subjects_affected="16" subjects_at_risk="2186"/>
                <counts group_id="E3" subjects_affected="12" subjects_at_risk="1530"/>
              </event>
              <event>
                <sub_title>Inf w/normal ANC or Gr 1-2 neutrophils - Soft tiss</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2125"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2186"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="1530"/>
              </event>
              <event>
                <sub_title>Inf w/normal ANC or Gr 1-2 neutrophils - Wound</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2125"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2186"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="1530"/>
              </event>
              <event>
                <sub_title>Inf w/normal ANC or Gr 1-2 neutrophils-Foreign bod</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2125"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2186"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="1530"/>
              </event>
              <event>
                <sub_title>Infection with normal ANC or Grade 1 or 2 neutroph</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2125"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2186"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="1530"/>
              </event>
              <event>
                <sub_title>Infection with unknown ANC - Appendix</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2125"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2186"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="1530"/>
              </event>
              <event>
                <sub_title>Infection with unknown ANC - Blood</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2125"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2186"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="1530"/>
              </event>
              <event>
                <sub_title>Infection with unknown ANC - Bronchus</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2125"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2186"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="1530"/>
              </event>
              <event>
                <sub_title>Infection with unknown ANC - Catheter-related</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2125"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2186"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="1530"/>
              </event>
              <event>
                <sub_title>Infection with unknown ANC - Duodenum</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2125"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2186"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="1530"/>
              </event>
              <event>
                <sub_title>Infection with unknown ANC - Foreign body (e.g., g</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2125"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2186"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="1530"/>
              </event>
              <event>
                <sub_title>Infection with unknown ANC - Heart (endocarditis)</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2125"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2186"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="1530"/>
              </event>
              <event>
                <sub_title>Infection with unknown ANC - Lung (pneumonia)</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2125"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2186"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="1530"/>
              </event>
              <event>
                <sub_title>Infection with unknown ANC - Skin (cellulitis)</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2125"/>
                <counts group_id="E2" subjects_affected="10" subjects_at_risk="2186"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="1530"/>
              </event>
              <event>
                <sub_title>Infection with unknown ANC - Soft tissue NOS</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2125"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2186"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="1530"/>
              </event>
              <event>
                <sub_title>Infection with unknown ANC - Upper airway NOS</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2125"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2186"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="1530"/>
              </event>
              <event>
                <sub_title>Infection with unknown ANC - Urinary tract NOS</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2125"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2186"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="1530"/>
              </event>
              <event>
                <sub_title>Infection with unknown ANC - Wound</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2125"/>
                <counts group_id="E2" subjects_affected="7" subjects_at_risk="2186"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="1530"/>
              </event>
              <event>
                <sub_title>Infection-Other</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2125"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2186"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="1530"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Injury, poisoning and procedural complications</title>
            <event_list>
              <event>
                <sub_title>Fracture</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2125"/>
                <counts group_id="E2" subjects_affected="11" subjects_at_risk="2186"/>
                <counts group_id="E3" subjects_affected="10" subjects_at_risk="1530"/>
              </event>
              <event>
                <sub_title>Intra-operative Injury-Other</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2125"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2186"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="1530"/>
              </event>
              <event>
                <sub_title>Intra-operative injury - Ovary</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2125"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2186"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="1530"/>
              </event>
              <event>
                <sub_title>Leak (including anastomotic), GI - Leak NOS</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2125"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2186"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="1530"/>
              </event>
              <event>
                <sub_title>Rash: dermatitis associated w/radiation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2125"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2186"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="1530"/>
              </event>
              <event>
                <sub_title>Seroma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2125"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2186"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="1530"/>
              </event>
              <event>
                <sub_title>Thrombosis/embolism (vascular access-related)</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2125"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2186"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="1530"/>
              </event>
              <event>
                <sub_title>Vessel injury-artery - Carotid</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2125"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2186"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="1530"/>
              </event>
              <event>
                <sub_title>Wound complication, non-infectious</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2125"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2186"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="1530"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Investigations</title>
            <event_list>
              <event>
                <sub_title>ALT, SGPT (serum glutamic pyruvic transaminase)</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2125"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="2186"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="1530"/>
              </event>
              <event>
                <sub_title>AST, SGOT</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2125"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="2186"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="1530"/>
              </event>
              <event>
                <sub_title>Alkaline phosphatase</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2125"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2186"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="1530"/>
              </event>
              <event>
                <sub_title>Bilirubin (hyperbilirubinemia)</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2125"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2186"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="1530"/>
              </event>
              <event>
                <sub_title>Creatinine</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2125"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2186"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="1530"/>
              </event>
              <event>
                <sub_title>Leukocytes (total WBC)</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2125"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="2186"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="1530"/>
              </event>
              <event>
                <sub_title>Lymphopenia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2125"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2186"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="1530"/>
              </event>
              <event>
                <sub_title>Neutrophils/granulocytes (ANC/AGC)</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2125"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="2186"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="1530"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Metabolism and nutrition disorders</title>
            <event_list>
              <event>
                <sub_title>Acidosis (metabolic or respiratory)</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2125"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2186"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="1530"/>
              </event>
              <event>
                <sub_title>Anorexia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2125"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2186"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="1530"/>
              </event>
              <event>
                <sub_title>Calcium, serum-low (hypocalcemia)</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2125"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2186"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="1530"/>
              </event>
              <event>
                <sub_title>Dehydration</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2125"/>
                <counts group_id="E2" subjects_affected="8" subjects_at_risk="2186"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="1530"/>
              </event>
              <event>
                <sub_title>Glucose, serum-high (hyperglycemia)</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2125"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2186"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="1530"/>
              </event>
              <event>
                <sub_title>Glucose, serum-low (hypoglycemia)</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2125"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="2186"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="1530"/>
              </event>
              <event>
                <sub_title>Magnesium, serum-low (hypomagnesemia)</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2125"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2186"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="1530"/>
              </event>
              <event>
                <sub_title>Pancreatic endocrine: glucose intolerance</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2125"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2186"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="1530"/>
              </event>
              <event>
                <sub_title>Phosphate, serum-low (hypophosphatemia)</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2125"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2186"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="1530"/>
              </event>
              <event>
                <sub_title>Potassium, serum-high (hyperkalemia)</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2125"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2186"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="1530"/>
              </event>
              <event>
                <sub_title>Potassium, serum-low (hypokalemia)</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2125"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="2186"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="1530"/>
              </event>
              <event>
                <sub_title>Sodium, serum-low (hyponatremia)</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2125"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="2186"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="1530"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Arthritis (non-septic)</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2125"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2186"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="1530"/>
              </event>
              <event>
                <sub_title>Muscle weakness, not d/t neuropathy - body/general</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2125"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2186"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="1530"/>
              </event>
              <event>
                <sub_title>Musculoskeletal/Soft Tissue-Other</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2125"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2186"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="1530"/>
              </event>
              <event>
                <sub_title>Osteonecrosis (avascular necrosis)</sub_title>
                <counts group_id="E1" subjects_affected="13" subjects_at_risk="2125"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="2186"/>
                <counts group_id="E3" subjects_affected="5" subjects_at_risk="1530"/>
              </event>
              <event>
                <sub_title>Pain - Back</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2125"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2186"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="1530"/>
              </event>
              <event>
                <sub_title>Pain - Bone</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2125"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2186"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="1530"/>
              </event>
              <event>
                <sub_title>Pain - Chest wall</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2125"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2186"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="1530"/>
              </event>
              <event>
                <sub_title>Pain - Extremity-limb</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2125"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2186"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="1530"/>
              </event>
              <event>
                <sub_title>Pain - Joint</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2125"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2186"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="1530"/>
              </event>
              <event>
                <sub_title>Pain - Muscle</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2125"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="2186"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="1530"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Neoplasms benign, malignant and unspecified (incl cysts and polyps)</title>
            <event_list>
              <event>
                <sub_title>Death - Disease progression NOS</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2125"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2186"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="1530"/>
              </event>
              <event>
                <sub_title>Pain - Tumor pain</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2125"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2186"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="1530"/>
              </event>
              <event>
                <sub_title>Secondary Malignancy-poss rel to cancer Tx</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2125"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2186"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="1530"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>Ataxia (incoordination)</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2125"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2186"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="1530"/>
              </event>
              <event>
                <sub_title>CNS cerebrovascular ischemia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2125"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="2186"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="1530"/>
              </event>
              <event>
                <sub_title>Cognitive disturbance</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2125"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2186"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="1530"/>
              </event>
              <event>
                <sub_title>Dizziness</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2125"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="2186"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="1530"/>
              </event>
              <event>
                <sub_title>Hemorrhage, CNS</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2125"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2186"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="1530"/>
              </event>
              <event>
                <sub_title>Neurology-Other</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2125"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2186"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="1530"/>
              </event>
              <event>
                <sub_title>Neuropathy: CN VII Motor-face; Sensory-taste</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2125"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2186"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="1530"/>
              </event>
              <event>
                <sub_title>Neuropathy: motor</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2125"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2186"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="1530"/>
              </event>
              <event>
                <sub_title>Neuropathy: sensory</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2125"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2186"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="1530"/>
              </event>
              <event>
                <sub_title>Ocular/Visual-Other</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2125"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2186"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="1530"/>
              </event>
              <event>
                <sub_title>Pain - Head/headache</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2125"/>
                <counts group_id="E2" subjects_affected="7" subjects_at_risk="2186"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="1530"/>
              </event>
              <event>
                <sub_title>Somnolence/depressed level of consciousness</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2125"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2186"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="1530"/>
              </event>
              <event>
                <sub_title>Syncope (fainting)</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2125"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="2186"/>
                <counts group_id="E3" subjects_affected="5" subjects_at_risk="1530"/>
              </event>
              <event>
                <sub_title>Vasovagal episode</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2125"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2186"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="1530"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Psychiatric disorders</title>
            <event_list>
              <event>
                <sub_title>Confusion</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2125"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2186"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="1530"/>
              </event>
              <event>
                <sub_title>Mood alteration - depression</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2125"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="2186"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="1530"/>
              </event>
              <event>
                <sub_title>Personality/behavioral</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2125"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2186"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="1530"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Renal and urinary disorders</title>
            <event_list>
              <event>
                <sub_title>Cystitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2125"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2186"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="1530"/>
              </event>
              <event>
                <sub_title>Glomerular filtration rate</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2125"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2186"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="1530"/>
              </event>
              <event>
                <sub_title>Hemorrhage, GU - Ureter</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2125"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2186"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="1530"/>
              </event>
              <event>
                <sub_title>Hemorrhage, GU - Urinary NOS</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2125"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2186"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="1530"/>
              </event>
              <event>
                <sub_title>Obstruction, GU - Ureter</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2125"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2186"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="1530"/>
              </event>
              <event>
                <sub_title>Pain - Bladder</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2125"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2186"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="1530"/>
              </event>
              <event>
                <sub_title>Pain - Kidney</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2125"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2186"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="1530"/>
              </event>
              <event>
                <sub_title>Proteinuria</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2125"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2186"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="1530"/>
              </event>
              <event>
                <sub_title>Renal failure</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2125"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2186"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="1530"/>
              </event>
              <event>
                <sub_title>Renal/Genitourinary-Other</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2125"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2186"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="1530"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Reproductive system and breast disorders</title>
            <event_list>
              <event>
                <sub_title>Hemorrhage, GU - Uterus</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2125"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2186"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="1530"/>
              </event>
              <event>
                <sub_title>Sexual/Reproductive Function-Other</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2125"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2186"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="1530"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>Bronchospasm, wheezing</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2125"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2186"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="1530"/>
              </event>
              <event>
                <sub_title>Cough</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2125"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2186"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="1530"/>
              </event>
              <event>
                <sub_title>Dyspnea (shortness of breath)</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2125"/>
                <counts group_id="E2" subjects_affected="10" subjects_at_risk="2186"/>
                <counts group_id="E3" subjects_affected="9" subjects_at_risk="1530"/>
              </event>
              <event>
                <sub_title>Hemorrhage, pulmonary/upper respiratory - Larynx</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2125"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2186"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="1530"/>
              </event>
              <event>
                <sub_title>Hypoxia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2125"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2186"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="1530"/>
              </event>
              <event>
                <sub_title>Pleural effusion (non-malignant)</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2125"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="2186"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="1530"/>
              </event>
              <event>
                <sub_title>Pneumonitis/pulmonary infiltrates</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2125"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="2186"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="1530"/>
              </event>
              <event>
                <sub_title>Pulmonary hypertension</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2125"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2186"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="1530"/>
              </event>
              <event>
                <sub_title>Pulmonary/Upper Respiratory-Other</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2125"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2186"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="1530"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Skin and subcutaneous tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Dermatology/Skin-Other</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2125"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2186"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="1530"/>
              </event>
              <event>
                <sub_title>Pruritus/itching</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2125"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2186"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="1530"/>
              </event>
              <event>
                <sub_title>Rash/desquamation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2125"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2186"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="1530"/>
              </event>
              <event>
                <sub_title>Rash: erythema multiforme</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2125"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2186"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="1530"/>
              </event>
              <event>
                <sub_title>Rash: hand-foot skin reaction</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2125"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2186"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="1530"/>
              </event>
              <event>
                <sub_title>Urticaria (hives, welts, wheals)</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2125"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2186"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="1530"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Vascular disorders</title>
            <event_list>
              <event>
                <sub_title>Hematoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2125"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2186"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="1530"/>
              </event>
              <event>
                <sub_title>Hypertension</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2125"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2186"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="1530"/>
              </event>
              <event>
                <sub_title>Hypotension</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2125"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2186"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="1530"/>
              </event>
              <event>
                <sub_title>Phlebitis (including superficial thrombosis)</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2125"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2186"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="1530"/>
              </event>
              <event>
                <sub_title>Thrombosis/thrombus/embolism</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2125"/>
                <counts group_id="E2" subjects_affected="9" subjects_at_risk="2186"/>
                <counts group_id="E3" subjects_affected="10" subjects_at_risk="1530"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <default_vocab>CTCAE (3.0)</default_vocab>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="1854" subjects_at_risk="2125"/>
                <counts group_id="E2" subjects_affected="1942" subjects_at_risk="2186"/>
                <counts group_id="E3" subjects_affected="1366" subjects_at_risk="1530"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Blood and lymphatic system disorders</title>
            <event_list>
              <event>
                <sub_title>Hemoglobin</sub_title>
                <counts group_id="E1" subjects_affected="376" subjects_at_risk="2125"/>
                <counts group_id="E2" subjects_affected="326" subjects_at_risk="2186"/>
                <counts group_id="E3" subjects_affected="251" subjects_at_risk="1530"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Constipation</sub_title>
                <counts group_id="E1" subjects_affected="230" subjects_at_risk="2125"/>
                <counts group_id="E2" subjects_affected="259" subjects_at_risk="2186"/>
                <counts group_id="E3" subjects_affected="180" subjects_at_risk="1530"/>
              </event>
              <event>
                <sub_title>Diarrhea</sub_title>
                <counts group_id="E1" subjects_affected="288" subjects_at_risk="2125"/>
                <counts group_id="E2" subjects_affected="447" subjects_at_risk="2186"/>
                <counts group_id="E3" subjects_affected="223" subjects_at_risk="1530"/>
              </event>
              <event>
                <sub_title>Heartburn/dyspepsia</sub_title>
                <counts group_id="E1" subjects_affected="138" subjects_at_risk="2125"/>
                <counts group_id="E2" subjects_affected="332" subjects_at_risk="2186"/>
                <counts group_id="E3" subjects_affected="280" subjects_at_risk="1530"/>
              </event>
              <event>
                <sub_title>Nausea</sub_title>
                <counts group_id="E1" subjects_affected="454" subjects_at_risk="2125"/>
                <counts group_id="E2" subjects_affected="555" subjects_at_risk="2186"/>
                <counts group_id="E3" subjects_affected="307" subjects_at_risk="1530"/>
              </event>
              <event>
                <sub_title>Pain - Abdomen NOS</sub_title>
                <counts group_id="E1" subjects_affected="133" subjects_at_risk="2125"/>
                <counts group_id="E2" subjects_affected="146" subjects_at_risk="2186"/>
                <counts group_id="E3" subjects_affected="100" subjects_at_risk="1530"/>
              </event>
              <event>
                <sub_title>Vomiting</sub_title>
                <counts group_id="E1" subjects_affected="158" subjects_at_risk="2125"/>
                <counts group_id="E2" subjects_affected="243" subjects_at_risk="2186"/>
                <counts group_id="E3" subjects_affected="123" subjects_at_risk="1530"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Edema: limb</sub_title>
                <counts group_id="E1" subjects_affected="243" subjects_at_risk="2125"/>
                <counts group_id="E2" subjects_affected="212" subjects_at_risk="2186"/>
                <counts group_id="E3" subjects_affected="163" subjects_at_risk="1530"/>
              </event>
              <event>
                <sub_title>Fatigue (asthenia, lethargy, malaise)</sub_title>
                <counts group_id="E1" subjects_affected="851" subjects_at_risk="2125"/>
                <counts group_id="E2" subjects_affected="749" subjects_at_risk="2186"/>
                <counts group_id="E3" subjects_affected="560" subjects_at_risk="1530"/>
              </event>
              <event>
                <sub_title>Fever in absence of neutropenia, ANC lt1.0x10e9/L</sub_title>
                <counts group_id="E1" subjects_affected="261" subjects_at_risk="2125"/>
                <counts group_id="E2" subjects_affected="82" subjects_at_risk="2186"/>
                <counts group_id="E3" subjects_affected="70" subjects_at_risk="1530"/>
              </event>
              <event>
                <sub_title>Flu-like syndrome</sub_title>
                <counts group_id="E1" subjects_affected="108" subjects_at_risk="2125"/>
                <counts group_id="E2" subjects_affected="24" subjects_at_risk="2186"/>
                <counts group_id="E3" subjects_affected="18" subjects_at_risk="1530"/>
              </event>
              <event>
                <sub_title>Pain-Other</sub_title>
                <counts group_id="E1" subjects_affected="185" subjects_at_risk="2125"/>
                <counts group_id="E2" subjects_affected="149" subjects_at_risk="2186"/>
                <counts group_id="E3" subjects_affected="122" subjects_at_risk="1530"/>
              </event>
              <event>
                <sub_title>Rigors/chills</sub_title>
                <counts group_id="E1" subjects_affected="109" subjects_at_risk="2125"/>
                <counts group_id="E2" subjects_affected="27" subjects_at_risk="2186"/>
                <counts group_id="E3" subjects_affected="18" subjects_at_risk="1530"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Injury, poisoning and procedural complications</title>
            <event_list>
              <event>
                <sub_title>Rash: dermatitis associated w/radiation</sub_title>
                <counts group_id="E1" subjects_affected="108" subjects_at_risk="2125"/>
                <counts group_id="E2" subjects_affected="100" subjects_at_risk="2186"/>
                <counts group_id="E3" subjects_affected="70" subjects_at_risk="1530"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Investigations</title>
            <event_list>
              <event>
                <sub_title>ALT, SGPT (serum glutamic pyruvic transaminase)</sub_title>
                <counts group_id="E1" subjects_affected="290" subjects_at_risk="2125"/>
                <counts group_id="E2" subjects_affected="540" subjects_at_risk="2186"/>
                <counts group_id="E3" subjects_affected="170" subjects_at_risk="1530"/>
              </event>
              <event>
                <sub_title>AST, SGOT</sub_title>
                <counts group_id="E1" subjects_affected="308" subjects_at_risk="2125"/>
                <counts group_id="E2" subjects_affected="581" subjects_at_risk="2186"/>
                <counts group_id="E3" subjects_affected="190" subjects_at_risk="1530"/>
              </event>
              <event>
                <sub_title>Alkaline phosphatase</sub_title>
                <counts group_id="E1" subjects_affected="114" subjects_at_risk="2125"/>
                <counts group_id="E2" subjects_affected="166" subjects_at_risk="2186"/>
                <counts group_id="E3" subjects_affected="77" subjects_at_risk="1530"/>
              </event>
              <event>
                <sub_title>Creatinine</sub_title>
                <counts group_id="E1" subjects_affected="205" subjects_at_risk="2125"/>
                <counts group_id="E2" subjects_affected="230" subjects_at_risk="2186"/>
                <counts group_id="E3" subjects_affected="127" subjects_at_risk="1530"/>
              </event>
              <event>
                <sub_title>Leukocytes (total WBC)</sub_title>
                <counts group_id="E1" subjects_affected="366" subjects_at_risk="2125"/>
                <counts group_id="E2" subjects_affected="370" subjects_at_risk="2186"/>
                <counts group_id="E3" subjects_affected="205" subjects_at_risk="1530"/>
              </event>
              <event>
                <sub_title>Lymphopenia</sub_title>
                <counts group_id="E1" subjects_affected="209" subjects_at_risk="2125"/>
                <counts group_id="E2" subjects_affected="181" subjects_at_risk="2186"/>
                <counts group_id="E3" subjects_affected="125" subjects_at_risk="1530"/>
              </event>
              <event>
                <sub_title>Metabolic/Laboratory-Other</sub_title>
                <counts group_id="E1" subjects_affected="120" subjects_at_risk="2125"/>
                <counts group_id="E2" subjects_affected="132" subjects_at_risk="2186"/>
                <counts group_id="E3" subjects_affected="67" subjects_at_risk="1530"/>
              </event>
              <event>
                <sub_title>Neutrophils/granulocytes (ANC/AGC)</sub_title>
                <counts group_id="E1" subjects_affected="160" subjects_at_risk="2125"/>
                <counts group_id="E2" subjects_affected="213" subjects_at_risk="2186"/>
                <counts group_id="E3" subjects_affected="100" subjects_at_risk="1530"/>
              </event>
              <event>
                <sub_title>Platelets</sub_title>
                <counts group_id="E1" subjects_affected="118" subjects_at_risk="2125"/>
                <counts group_id="E2" subjects_affected="140" subjects_at_risk="2186"/>
                <counts group_id="E3" subjects_affected="51" subjects_at_risk="1530"/>
              </event>
              <event>
                <sub_title>Weight gain</sub_title>
                <counts group_id="E1" subjects_affected="124" subjects_at_risk="2125"/>
                <counts group_id="E2" subjects_affected="137" subjects_at_risk="2186"/>
                <counts group_id="E3" subjects_affected="81" subjects_at_risk="1530"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Metabolism and nutrition disorders</title>
            <event_list>
              <event>
                <sub_title>Calcium, serum-high (hypercalcemia)</sub_title>
                <counts group_id="E1" subjects_affected="109" subjects_at_risk="2125"/>
                <counts group_id="E2" subjects_affected="97" subjects_at_risk="2186"/>
                <counts group_id="E3" subjects_affected="61" subjects_at_risk="1530"/>
              </event>
              <event>
                <sub_title>Calcium, serum-low (hypocalcemia)</sub_title>
                <counts group_id="E1" subjects_affected="196" subjects_at_risk="2125"/>
                <counts group_id="E2" subjects_affected="162" subjects_at_risk="2186"/>
                <counts group_id="E3" subjects_affected="111" subjects_at_risk="1530"/>
              </event>
              <event>
                <sub_title>Glucose, serum-high (hyperglycemia)</sub_title>
                <counts group_id="E1" subjects_affected="484" subjects_at_risk="2125"/>
                <counts group_id="E2" subjects_affected="429" subjects_at_risk="2186"/>
                <counts group_id="E3" subjects_affected="283" subjects_at_risk="1530"/>
              </event>
              <event>
                <sub_title>Glucose, serum-low (hypoglycemia)</sub_title>
                <counts group_id="E1" subjects_affected="119" subjects_at_risk="2125"/>
                <counts group_id="E2" subjects_affected="84" subjects_at_risk="2186"/>
                <counts group_id="E3" subjects_affected="58" subjects_at_risk="1530"/>
              </event>
              <event>
                <sub_title>Magnesium, serum-low (hypomagnesemia)</sub_title>
                <counts group_id="E1" subjects_affected="120" subjects_at_risk="2125"/>
                <counts group_id="E2" subjects_affected="88" subjects_at_risk="2186"/>
                <counts group_id="E3" subjects_affected="82" subjects_at_risk="1530"/>
              </event>
              <event>
                <sub_title>Phosphate, serum-low (hypophosphatemia)</sub_title>
                <counts group_id="E1" subjects_affected="148" subjects_at_risk="2125"/>
                <counts group_id="E2" subjects_affected="87" subjects_at_risk="2186"/>
                <counts group_id="E3" subjects_affected="80" subjects_at_risk="1530"/>
              </event>
              <event>
                <sub_title>Potassium, serum-low (hypokalemia)</sub_title>
                <counts group_id="E1" subjects_affected="172" subjects_at_risk="2125"/>
                <counts group_id="E2" subjects_affected="189" subjects_at_risk="2186"/>
                <counts group_id="E3" subjects_affected="88" subjects_at_risk="1530"/>
              </event>
              <event>
                <sub_title>Sodium, serum-low (hyponatremia)</sub_title>
                <counts group_id="E1" subjects_affected="114" subjects_at_risk="2125"/>
                <counts group_id="E2" subjects_affected="106" subjects_at_risk="2186"/>
                <counts group_id="E3" subjects_affected="78" subjects_at_risk="1530"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Arthritis (non-septic)</sub_title>
                <counts group_id="E1" subjects_affected="206" subjects_at_risk="2125"/>
                <counts group_id="E2" subjects_affected="197" subjects_at_risk="2186"/>
                <counts group_id="E3" subjects_affected="143" subjects_at_risk="1530"/>
              </event>
              <event>
                <sub_title>Pain - Back</sub_title>
                <counts group_id="E1" subjects_affected="295" subjects_at_risk="2125"/>
                <counts group_id="E2" subjects_affected="253" subjects_at_risk="2186"/>
                <counts group_id="E3" subjects_affected="213" subjects_at_risk="1530"/>
              </event>
              <event>
                <sub_title>Pain - Bone</sub_title>
                <counts group_id="E1" subjects_affected="614" subjects_at_risk="2125"/>
                <counts group_id="E2" subjects_affected="390" subjects_at_risk="2186"/>
                <counts group_id="E3" subjects_affected="303" subjects_at_risk="1530"/>
              </event>
              <event>
                <sub_title>Pain - Extremity-limb</sub_title>
                <counts group_id="E1" subjects_affected="260" subjects_at_risk="2125"/>
                <counts group_id="E2" subjects_affected="231" subjects_at_risk="2186"/>
                <counts group_id="E3" subjects_affected="173" subjects_at_risk="1530"/>
              </event>
              <event>
                <sub_title>Pain - Joint</sub_title>
                <counts group_id="E1" subjects_affected="1071" subjects_at_risk="2125"/>
                <counts group_id="E2" subjects_affected="968" subjects_at_risk="2186"/>
                <counts group_id="E3" subjects_affected="756" subjects_at_risk="1530"/>
              </event>
              <event>
                <sub_title>Pain - Muscle</sub_title>
                <counts group_id="E1" subjects_affected="488" subjects_at_risk="2125"/>
                <counts group_id="E2" subjects_affected="339" subjects_at_risk="2186"/>
                <counts group_id="E3" subjects_affected="294" subjects_at_risk="1530"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>Dizziness</sub_title>
                <counts group_id="E1" subjects_affected="196" subjects_at_risk="2125"/>
                <counts group_id="E2" subjects_affected="157" subjects_at_risk="2186"/>
                <counts group_id="E3" subjects_affected="134" subjects_at_risk="1530"/>
              </event>
              <event>
                <sub_title>Neuropathy: sensory</sub_title>
                <counts group_id="E1" subjects_affected="464" subjects_at_risk="2125"/>
                <counts group_id="E2" subjects_affected="447" subjects_at_risk="2186"/>
                <counts group_id="E3" subjects_affected="311" subjects_at_risk="1530"/>
              </event>
              <event>
                <sub_title>Pain - Head/headache</sub_title>
                <counts group_id="E1" subjects_affected="310" subjects_at_risk="2125"/>
                <counts group_id="E2" subjects_affected="270" subjects_at_risk="2186"/>
                <counts group_id="E3" subjects_affected="205" subjects_at_risk="1530"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Psychiatric disorders</title>
            <event_list>
              <event>
                <sub_title>Insomnia</sub_title>
                <counts group_id="E1" subjects_affected="345" subjects_at_risk="2125"/>
                <counts group_id="E2" subjects_affected="310" subjects_at_risk="2186"/>
                <counts group_id="E3" subjects_affected="204" subjects_at_risk="1530"/>
              </event>
              <event>
                <sub_title>Mood alteration - anxiety</sub_title>
                <counts group_id="E1" subjects_affected="178" subjects_at_risk="2125"/>
                <counts group_id="E2" subjects_affected="159" subjects_at_risk="2186"/>
                <counts group_id="E3" subjects_affected="106" subjects_at_risk="1530"/>
              </event>
              <event>
                <sub_title>Mood alteration - depression</sub_title>
                <counts group_id="E1" subjects_affected="236" subjects_at_risk="2125"/>
                <counts group_id="E2" subjects_affected="227" subjects_at_risk="2186"/>
                <counts group_id="E3" subjects_affected="151" subjects_at_risk="1530"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Reproductive system and breast disorders</title>
            <event_list>
              <event>
                <sub_title>Pain - Breast</sub_title>
                <counts group_id="E1" subjects_affected="129" subjects_at_risk="2125"/>
                <counts group_id="E2" subjects_affected="144" subjects_at_risk="2186"/>
                <counts group_id="E3" subjects_affected="102" subjects_at_risk="1530"/>
              </event>
              <event>
                <sub_title>Vaginal dryness</sub_title>
                <counts group_id="E1" subjects_affected="128" subjects_at_risk="2125"/>
                <counts group_id="E2" subjects_affected="137" subjects_at_risk="2186"/>
                <counts group_id="E3" subjects_affected="90" subjects_at_risk="1530"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>Cough</sub_title>
                <counts group_id="E1" subjects_affected="216" subjects_at_risk="2125"/>
                <counts group_id="E2" subjects_affected="216" subjects_at_risk="2186"/>
                <counts group_id="E3" subjects_affected="143" subjects_at_risk="1530"/>
              </event>
              <event>
                <sub_title>Dyspnea (shortness of breath)</sub_title>
                <counts group_id="E1" subjects_affected="185" subjects_at_risk="2125"/>
                <counts group_id="E2" subjects_affected="133" subjects_at_risk="2186"/>
                <counts group_id="E3" subjects_affected="116" subjects_at_risk="1530"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Skin and subcutaneous tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Hair loss/Alopecia (scalp or body)</sub_title>
                <counts group_id="E1" subjects_affected="138" subjects_at_risk="2125"/>
                <counts group_id="E2" subjects_affected="120" subjects_at_risk="2186"/>
                <counts group_id="E3" subjects_affected="90" subjects_at_risk="1530"/>
              </event>
              <event>
                <sub_title>Rash/desquamation</sub_title>
                <counts group_id="E1" subjects_affected="306" subjects_at_risk="2125"/>
                <counts group_id="E2" subjects_affected="307" subjects_at_risk="2186"/>
                <counts group_id="E3" subjects_affected="194" subjects_at_risk="1530"/>
              </event>
              <event>
                <sub_title>Sweating (diaphoresis)</sub_title>
                <counts group_id="E1" subjects_affected="97" subjects_at_risk="2125"/>
                <counts group_id="E2" subjects_affected="97" subjects_at_risk="2186"/>
                <counts group_id="E3" subjects_affected="79" subjects_at_risk="1530"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Vascular disorders</title>
            <event_list>
              <event>
                <sub_title>Hot flashes/flushes</sub_title>
                <counts group_id="E1" subjects_affected="795" subjects_at_risk="2125"/>
                <counts group_id="E2" subjects_affected="808" subjects_at_risk="2186"/>
                <counts group_id="E3" subjects_affected="579" subjects_at_risk="1530"/>
              </event>
              <event>
                <sub_title>Hypertension</sub_title>
                <counts group_id="E1" subjects_affected="94" subjects_at_risk="2125"/>
                <counts group_id="E2" subjects_affected="127" subjects_at_risk="2186"/>
                <counts group_id="E3" subjects_affected="60" subjects_at_risk="1530"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.</restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>SWOG statistician</name_or_title>
      <organization>SWOG Statistics &amp; Data Management Center</organization>
      <phone>2066674263</phone>
      <email>jmiao@fredhutch.org</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

